Archive · 3 Oct 2025
FDA Approves Generic Mifepristone, Sparking Controversy
The FDA, a government agency that checks medicines, approved a new generic version of the abortion pill, mifepristone.
This means another company besides the original maker can now sell it.
Anti-abortion groups are not happy about this, and some are criticizing the decision.
This is because mifepristone is used to end early pregnancies.
This decision has caused a lot of discussion among people who have different views on abortion.
The FDA approved a second generic version of mifepristone.
The new generic is manufactured by Evita Solutions.
Approval triggered pushback from anti-abortion groups.
The move was seen as a surprise to some conservative groups.
Evita expects its version to be available in January.
- Who
- US FDA, Evita Solutions, Anti-abortion groups
- What
- FDA approved a second generic version of mifepristone.
- When
- Recently, announced Thursday
- Where
- United States
- Why
- The FDA is required to approve generics proven identical to brand-name drugs. The approval has been criticized by anti-abortion groups and politicians.
Supporters of Mifepristone Access
Critics of Mifepristone
Mifepristone Approval
Supporters of Mifepristone Access
The FDA's approval of generic drugs is a routine process.
Critics of Mifepristone
The FDA's approval of mifepristone is a step that raises concerns for the anti-abortion groups.
- Drug
- Mifepristone
- Generic Approval
- Granted by US FDA
- Company
- Evita Solutions
- Original Approval
- 2000
- Use
- Medication abortion
